Cyclacel Pharmaceuticals, Inc. (CYCC)

Cyclacel Pharmaceuticals Statistics

Total Valuation

CYCC has a market cap or net worth of $2.70 million. The enterprise value is -$404,246.

Market Cap	2.70M
Enterprise Value	-404,246

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CYCC has 6.29 million shares outstanding. The number of shares has increased by 119.06% in one year.

Current Share Class	6.29M
Shares Outstanding	6.29M
Shares Change (YoY)	+119.06%
Shares Change (QoQ)	+502.27%
Owned by Insiders (%)	1.33%
Owned by Institutions (%)	5.88%
Float	6.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.92
Forward PS	29.75
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.77

Current Ratio	0.77
Quick Ratio	0.67
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-863.11

Financial Efficiency

Return on equity (ROE) is -807.39% and return on invested capital (ROIC) is -574.73%.

Return on Equity (ROE)	-807.39%
Return on Assets (ROA)	-108.63%
Return on Capital (ROIC)	-574.73%
Revenue Per Employee	$6,167
Profits Per Employee	-$1.12M
Employee Count	12
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-2.40M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.62% in the last 52 weeks. The beta is 0.35, so CYCC's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-89.62%
50-Day Moving Average	0.70
200-Day Moving Average	1.56
Relative Strength Index (RSI)	40.87
Average Volume (20 Days)	1,484,369

Short Selling Information

The latest short interest is 672,048, so 10.69% of the outstanding shares have been sold short.

Short Interest	672,048
Short Previous Month	66,765
Short % of Shares Out	10.69%
Short % of Float	10.83%
Short Ratio (days to cover)	0.03

Income Statement

In the last 12 months, CYCC had revenue of $74,000 and -$13.48 million in losses. Loss per share was -$6.26.

Revenue	74,000
Gross Profit	74,000
Operating Income	-15.54M
Pretax Income	-22.73M
Net Income	-13.48M
EBITDA	-15.52M
EBIT	-15.54M
Loss Per Share	-$6.26

Balance Sheet

Cash & Cash Equivalents	2.98M
Total Debt	n/a
Net Cash	2.98M
Net Cash Per Share	$0.47
Equity (Book Value)	-970,000
Book Value Per Share	-0.45
Working Capital	-1.44M

Cash Flow

Operating Cash Flow	-10.54M
Capital Expenditures	n/a
Free Cash Flow	-10.54M
FCF Per Share	-$1.68

Margins

Gross Margin	100.00%
Operating Margin	-20,994.59%
Pretax Margin	-21,390.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,167.93%

Dividends & Yields

CYCC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-119.06%
Shareholder Yield	-119.06%
Earnings Yield	-522.59%
FCF Yield	-408.74%

Analyst Forecast

The average price target for CYCC is $11.00, which is 2,462.31% higher than the current price. The consensus rating is "Buy".

Price Target	$11.00
Price Target Difference	2,462.31%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	178.69%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on December 18, 2023. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Dec 18, 2023
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

CYCC has an Altman Z-Score of -123.07 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-123.07
Piotroski F-Score	1